Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neuroendocrine Tumors × Immunotherapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Histiocytosis 1 Head and Neck Neoplasms 1 Glioblastoma 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Brain Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Everolimus 16 Octreotide 6 pembrolizumab 5 lanreotide 5 Sunitinib 5 Magnetic Resonance Spectroscopy 5 gallium Ga 68 dotatate 4 cabozantinib 4 Nivolumab 4 Carboplatin 4 telotristat ethyl 3 lenvatinib 3 arginyllysine 3 Specimen Handling 3 Etoposide 3 Erlotinib Hydrochloride 3 Bevacizumab 3 surufatinib 2 pazopanib 2 pasireotide 2 lutetium Lu 177 dotatate 2 amino-acid, glucose, and electrolyte solution 2 X-Rays 2 Temozolomide 2 Sorafenib 2 Phantoms, Imaging 2 Paclitaxel 2 Oxaliplatin 2 Ipilimumab 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡